TIGAR and pancreatic neoplasm: Using a pancreatic tumor model, we show that deletion of Tigar drives increased ROS and a decrease in the development of premalignant PanIN lesions, consistent with an enhanced proliferative capacity of cancer cells with higher TIGAR expression.